Search

Your search keyword '"Kuo-Chen, Chan"' showing total 23 results

Search Constraints

Start Over You searched for: Author "Kuo-Chen, Chan" Remove constraint Author: "Kuo-Chen, Chan"
23 results on '"Kuo-Chen, Chan"'

Search Results

1. Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration

2. Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial

3. A Prospective Study of Key Correlates for Household Transmission of SARS-CoV-2

4. Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial

5. Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia

6. Subcutaneous REGEN-COV Antibody Combination for Covid-19 Prevention

7. Subcutaneous REGEN-COV Antibody Combination in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial

8. COVID-19 prevention with subcutaneous administration of the monoclonal antibodies casirivimab and imdevimab: Subgroup analysis in participants with cardiovascular disease and diabetes

9. The effect of evinacumab on LDL-C goal attainment in patients with homozygous familial hypercholesterolemia

10. Abstract 14270: The Effect of Evinacumab on Apheresis Eligibility in Patients With Homozygous Familial Hypercholesterolemia

11. Abstract 14407: The Longer-term Efficacy and Safety of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia

12. Abstract 14267: Evinacumab Lowers LDL-C in Patients With Homozygous Familial Hypercholesterolemia Irrespective of Background Lipid-lowering Medication

13. The Efficacy and Safety of Evinacumab in Homozygous Familial Hypercholesterolemia Patients with Little to No Low-Density Lipoprotein Receptor Activity

14. Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants in Patient Lymphocytes to Assess the Effect of Evinacumab in Homozygous Familial Hypercholesterolemia Patients With a Spectrum of LDLR Activity

15. Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis

16. 5938Efficacy of evinacumab in homozygous familial hypercholesterolemia patients with null or non-null LDL-receptor mutations and on various background therapies

17. ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia

18. Safety and Efficacy of Evinacumab, A Monoclonal Antibody to ANGPTL3, In Homozygous Familial Hypercholesterolemia

19. Effet de l’ajustement de la posologie sur le maintien de la réponse clinique et la sécurité du dupilumab chez les patients atteints de dermatite atopique (LIBERTY AD SOLO-CONTINUE)

20. Safety and efficacy of evinacumab, a monoclonal antibody to ANGPTL3, in patients with homozygous familial hypercholesterolemia: A single-arm, open-label, proof-of-concept study

22. ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia.

23. [Improving the Accuracy of Patient Self-Care After Joint Replacement Surgery].

Catalog

Books, media, physical & digital resources